Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-438-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 April 2011 - 01 June 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- The study was conducted according to official EC and OECD test guidelines, and in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1997-07-21
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Version / remarks:
- 1998-08
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH (1996) Guidelilnes S2A
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH (1998) Guideline S2B
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Reaction mass of diiron carbide, diiron phosphide and triiron phosphide
- EC Number:
- 701-438-1
- Cas Number:
- not applicable
- Molecular formula:
- not applicable (multi constituent substance)
- IUPAC Name:
- Reaction mass of diiron carbide, diiron phosphide and triiron phosphide
Constituent 1
Method
- Target gene:
- not applicable
Species / strain
- Species / strain / cell type:
- lymphocytes: human
- Details on mammalian cell type (if applicable):
- CELLS USED
For lymphocytes:
- Sex, age and number of blood donors: two healthy, non-smoking male donors
- Whether whole blood or separated lymphocytes were used: whole blood
- Whether blood from different donors were pooled or not: blood from donors was pooled
- Mitogen used for lymphocytes: phytohaemagglutinin (PHA)
- In this laboratory the cell cycle time for human lymphocytes in whole blood culture is approximately 13-14 hours.
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature, if applicable: TRPMI 1640 tissue culture medium supplemented with 10% foetal calf serum, 0.2 IU/mL sodium heparin, 20 IU/mL penicillin / 20 μg/mL streptomycin and 2.0 mM glutamine. Aliquots (0.4 mL blood : 4.5 mL medium : 0.1 mL phytohaemagglutinin) of the cell suspension were placed in sterile universal containers and incubated at 37°C in a 5% CO2 atmosphere for approximately 48 hours. The cultures were gently shaken daily to resuspend the cells.
- Cytokinesis block (if used):
- colcemid (final concentration: 0.1 µg/mL)
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Mix
- The S9 fraction was obtained from male Sprague-Dawley derived rats, dosed with phenobarbital and 5,6-benzoflavone to stimulate mixed-function oxidases in the liver. The S9 fraction was purchased from a commercial source (batch number 2697) and stored at -80°C or below.
- S9 mix contained: S9 fraction (10% v/v : test 1 and 25% v/v : test 2), MgCl2 (8 mM), KCl (33 mM), sodium phosphate buffer pH 7.4 (100 mM), glucose-6-phosphate (5 mM), NADP (4 mM). - Test concentrations with justification for top dose:
- 3.25, 8.13, 20.33, 50.82, 127.05, 317.62, 794.04, and 1985.1 µg/mL (standard limit concentration).
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: culture medium
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- Used in the absence of S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- Used in the presence of S9 mix
- Details on test system and experimental conditions:
- METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in suspension
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable: 48 hours in PHA
- Exposure duration/duration of treatment: 3 hours and 21 hours
- Harvest time after the end of treatment (sampling/recovery times): 18 hours recovery (3-hour treatment); no recovery (21-hour treatment)
FOR CHROMOSOME ABERRATION AND MICRONUCLEUS:
- Spindle inhibitor (cytogenetic assays): Two hours before the cells were harvested, mitotic activity was arrested by addition of Colcemid to each culture at a final concentration of 0.1 μg/mL.
- Methods of slide preparation and staining technique used including the stain used (for cytogenetic assays): The cell pellets were treated with a hypotonic solution (0.075M KCl), pre-warmed at 37°C. After a 10-minute period of incubation at 37°C, the suspensions were centrifuged at 500 g for 5 minutes and the cell pellets fixed by addition of freshly prepared cold fixative (3 parts methanol : 1 part glacial acetic acid).The cell pellets were resuspended, then centrifuged at 500 g for 5 minutes and finally resuspended in a small volume of fresh fixative. A few drops of the cell suspensions were dropped onto pre-cleaned microscope slides and allowed to air dry. The slides were then stained in 10% Giemsa, prepared in buffered water (pH 6.8). After rinsing in buffered water the slides were left to air-dry and mounted in DPX.
- Number of cells spread and analysed per concentration (number of replicate cultures and total number of cells scored): Duplicates cultures were used. 100 metaphase figures were examined from each culture.
- Criteria for scoring chromosome aberrations (selection of analysable cells and aberration identification): Chromosome aberrations were scored according to the classification of the ISCN (1985)*. Only cells with 44 - 48 chromosomes were analysed. Polyploid and endoreduplicated cells were noted when seen. The vernier readings of all aberrant metaphase figures were recorded.
- Determination of polyploidy: Polyploid cells were noted when seen
- Determination of endoreplication: Endoreduplicated cells were noted when seen
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: mitotic index (MI)
*References:
- ISCN (1985) An International System for Human Cytogenetic Nomenclature, HARNDEN, D.G. and KLINGER, H. P. (Eds). S. Karger AG, Basel. - Evaluation criteria:
- An assay is considered to be acceptable if the negative and positive control values lie withinthe current historical control range.
The test substance is considered to cause a positive response if the following conditions are met:
- Statistically significant increases (p<0.01) in the frequency of metaphases with aberrant chromosomes (excluding gaps) are observed at one or more test concentration.
- The increases exceed the solvent control range of this laboratory, taken at the 99% confidence limit.
- The increases are reproducible between replicate cultures.
- The increases are not associated with large changes in pH, osmolality of the treatment medium or extreme toxicity.
- Evidence of a concentration-related response is considered to support the conclusion.
A negative response is claimed if no statistically significant increases in the number of aberrant cells above concurrent control frequencies are observed, at any concentration.
A further evaluation may be carried out if the above criteria for a positive or a negative response are not met. - Statistics:
- The number of aberrant metaphase cells in each test substance group was compared with the solvent control value using the one-tailed Fisher exact test.
A Cochran-Armitage test for trend was applied to the control and all test substance groups. If this is significant at the 1% level, the test is reiterated excluding the
highest concentration group - this process continues until the trend test is no longer significant.
D20s (the minimum concentration (mg/mL) at which aberrations were found in 20% of metaphases) were estimated using logistic regression on a log(concentration) scale, allowing the number of control aberrations to be non-zero.
Results and discussion
Test results
- Species / strain:
- lymphocytes: Human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Toxicity data
In the absence of S9 mix following 21 hour continuous treatment, Ferrophosphorus (Fe3P) caused no significant reduction in the mitotic index at 1985.1 μg/mL, compared to the solvent control value. The concentrations selected for metaphase analysis were 3.25, 794.04 and 1985.1 μg/mL.In the presence of S9 mix (5% v/v final concentration) following 3 hour treatment, Ferrophosphorus (Fe3P) caused no significant reduction in the mitotic index at 1985.1 μg/mL, compared to the solvent control value. The concentrations selected for metaphase analysis were 8.13, 794.04 and 1985.1 μg/mL.
Metaphase analysis
In both the absence and the presence of S9 mix, Ferrophosphorus (Fe3P) caused no statistically significant increases in the proportion of cells with chromosomal aberrations at any concentration, when compared with the solvent control. All mean values for the solvent control (culture medium), and all Ferrophosphorus (Fe3P) treatment concentrations were within the laboratory historical control range, when taken at the 99% confidence limit. Both positive control compounds, Mitomycin C and Cyclophosphamide, caused statistically significant increases (p<0.001) in the proportion of aberrant cells. This demonstrated the efficacy of the S9 mix and the sensitivity of the test system.
Polyploid analysis
No statistically significant increases in polyploid metaphases were observed during metaphase analysis in either test.
Applicant's summary and conclusion
- Conclusions:
- It is concluded that the test substance Ferrophosphorus (Fe3P) has shown no evidence of causing an increase in the frequency of structural chromosome aberrations in this in vitro cytogenetic test system, under the experimental conditions described.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.